MedPath

The Sakakibara Health Integrative Profile of Atherosclerotic-Carcinogenesis Hypothesis (SHIP-AC)

Completed
Conditions
Atheroscleroses, Coronary
Atherosclerosis of Artery
Cancers
Interventions
Other: incidece of cancers
Registration Number
NCT04198896
Lead Sponsor
Sakakibara Heart Institute
Brief Summary

As previously reported (IJC Heart \& Vasculature 2017; 17: 11.), our epidemiological analysis showing high incidence of cancers in patients with atherosclerotic cardiovascular diseases as compared with those with non-atherosclerotic cardiovascular diseases may imply a clinical possibility of a role of atherosclerosis in cancer developments. In the present study, to address our hypothesis that cancer developments may come with a strength of atherosclerosis, we traced an incidence of cancers in a total of 8,856 patients with coronary artery diseases (CAD) for a median follow-up of 1,095 days (interquartile range, 719-1,469 days) using the Sakakibara Health Integrative Profile (SHIP) database.

Detailed Description

In accordance with a presence or absence of poly-arterial diseases such as aortic and/or peripheral artery diseases as an indicator of a strength of atherosclerosis, an incidence of cancers and all-cause death in two cohorts of 8,140 patients with CAD-only and 716 with CAD with poly-arterial diseases were evaluated to track an incidence of cancers and ali-cause mortality during median follou-up periods of 3 to 4 years.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
8856
Inclusion Criteria
  • patients with diagnosed coronary artery diseases without a dignosis of cancers at the entry of SHIP between January 2009 and July 2014.
Exclusion Criteria
  • patients with diagnosed coronary artery diseases who had already been diagnosed with any cancers at the time of enrollment in the SHIP, and who were not followed-up after the entry of SHIP.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
CAD-onlyincidece of cancerspatients with diagnosed coronary artery diseases (CAD) without any other atherosclerotic cardiovascuar diseases at the entry of SHIP
CAD with poly-arterial diseasesincidece of cancerspatients with diagnosed coronary artery diseases (CAD) with other atherosclerotic cardiovascuar diseases such as any of aortic and/or peripheral artery diseases at the entry of SHIP
Primary Outcome Measures
NameTimeMethod
inicidence of cancersthrough study completion, an average of 3 years

number of all types of cancers during follow-up periods

Secondary Outcome Measures
NameTimeMethod
all-cause mortalitythrough study completion, an average of 3 years

number of all types of death during follow-up periods

© Copyright 2025. All Rights Reserved by MedPath